Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Progyny Inc(PGNY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PGNY
09/25/2026: PGNY (3-star) is currently NOT-A-BUY. Pass it for now.
Progyny Inc is a leading provider of fertility and family-building benefit solutions for large employers in the United States. Its primary strength lies in a high-touch service model that utilizes a network of vetted specialists to improve clinical outcomes and manage costs. The company's growth story is driven by the rising demand for fertility benefits as a key employer-provided health perk. However, Progyny faces risks including client concentration, potential competition from large health insurers, and macroeconomic pressures that could impact employer spending. It is best suited for growth-oriented investors who should monitor client retention rates and the company's ability to successfully expand its services beyond core fertility offerings.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Progyny is a high-growth company operating in a rapidly expanding niche of the employer-sponsored benefits market. |
| Momentum investor | Mixed fit | Momentum performance depends heavily on the company's ability to maintain high growth rates against evolving market expectations. |
| Value investor | Weak fit | The company typically trades at a premium valuation reflecting its growth potential, which may not satisfy traditional value metrics. |
| Dividend investor | Weak fit | Progyny does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | High market volatility and client concentration make this stock unsuitable for low-risk investment mandates. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Growth stocks in the healthcare sector often experience significant price swings based on quarterly earnings reports. |
| Valuation risk | Medium / high | Investors pay a premium for growth, making the stock sensitive to downward revisions in growth projections. |
| Competition risk (specialized and health plan competition) | Medium | Increased competition from large health insurers could compress margins and challenge market share growth. |
| Business quality | Strong | The company has a proven, highly scalable business model with a high retention rate among large enterprise clients. |
| Dividend income | Low / none | Investors should not expect any income from this stock as capital is reserved for growth. |
| Execution risk | Medium | Maintaining quality and cost-effectiveness while scaling to new markets is a key operational challenge. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 51.83% | Avg. Invested days 48 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.95B USD | Price to earnings Ratio 27.65 | 1Y Target Price 34.42 |
Price to earnings Ratio 27.65 | 1Y Target Price 34.42 | ||
Volume (30-day avg) 1.1M shares | Beta 0.99 | 52 Weeks Range 16.10 - 33.06 | Updated Date 09/26/2026 |
52 Weeks Range 16.10 - 33.06 | Updated Date 09/26/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.92 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Fertility Benefits Services | Revenue generated from management fees and margin on fertility services provided through the Progyny network. | Progyny earns money primarily by managing fertility benefits for employers, charging them for access to a high-quality clinic network. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 27.65 | Forward PE 11.85 | Enterprise Value 1.77B | Price to Sales(TTM) 1.49 |
Enterprise Value 1.77B | Price to Sales(TTM) 1.49 | ||
Enterprise Value to Revenue 1.35 | Enterprise Value to EBITDA 14.99 | Shares Outstanding 76.73M | Shares Floating 70.15M |
Shares Outstanding 76.73M | Shares Floating 70.15M | ||
Percent Insiders 1.98 | Percent Institutions 110.73 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Progyny Inc
Exchange NASDAQ | Headquarters New York, NY, United States | ||
IPO Launch date 2019-10-25 | CEO & Director Mr. Peter Anevski CPA | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 835 | Website https://www.progyny.com |
Full time employees 835 | Website https://www.progyny.com | ||
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.